Womens Health Investment Outlook 2026

Point of caution for investors –Coverage and regulatory risk: Insurance gaps (particularly around menopause), evolving telehealth and AI compliance rules, and data privacy constraints could delay large-scale payer integration. 3.3 Remote maternal health monitoring Current activity Remote maternal health monitoring is a nascent but rapidly expanding segment, with an estimated total global addressable market of $2 billion in 2025. Approximately 100 companies currently operate in this space, with $1 billion raised across just over 140 funding events in the past five years. Women’s health-specific remote health monitoring companies attracted over 60% of total funding in this segment in the past five years. Between 2020 and 2025, private funding deals remained stable, led primarily by early- and growth-stage venture investors. In the US, public reimbursement mechanisms, primarily through Medicare’s remote patient monitoring (RPM) and remote therapeutic monitoring (RTM) codes, as well as select Medicaid-backed RPM pilots, have validated commercial models, while early liquidity events, including special purpose acquisition company (SPAC) listings, indicate emerging exit pathways. Hospitals, payers and telehealth platforms are increasingly collaborating with device and software innovators to align reimbursement and accelerate adoption. In 2024, the NIH allocated approximately $1 billion across maternal health and maternal morbidity and mortality.80 Investment events, remote maternal health monitoring FIGURE 11 Source: Pitchbook, CapIQ, Crunchbase, Boston Consulting GroupPre-seed/seed Early-stage VC Later -stage VC Other Private funding $ UndisclosedPrivate investment funding deals for remote maternal health monitoring 74% of deals disclosed funding 0 5 20 55 700 152 1 0 20000 4 209 191 85198 34 30 28 20Deal Total funding ($M) 2021 2022 2023 2024 Women’s Health Investment Outlook 24